J03 Evaluating tominersen effect on self-reported quality of life (QoL) with high-frequency longitudinal, digital euroqol 5-dimensions 5-level (EQ-5D-5L) survey in generation HD1, a phase III trial of tominersen in adult individuals with manifest Huntington’s disease (HD)
D. Berchtold, Johannes Rennig, Cedric Simillion, F. Lipsmeier, P. McColgan, M. Lindemann, Jonas F. Dorn
{"title":"J03 Evaluating tominersen effect on self-reported quality of life (QoL) with high-frequency longitudinal, digital euroqol 5-dimensions 5-level (EQ-5D-5L) survey in generation HD1, a phase III trial of tominersen in adult individuals with manifest Huntington’s disease (HD)","authors":"D. Berchtold, Johannes Rennig, Cedric Simillion, F. Lipsmeier, P. McColgan, M. Lindemann, Jonas F. Dorn","doi":"10.1136/jnnp-2022-ehdn.253","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":251913,"journal":{"name":"J: Clinical therapeutics","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"J: Clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2022-ehdn.253","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
